XML 97 R41.htm IDEA: XBRL DOCUMENT v3.20.1
Reportable Segment Information (Tables)
6 Months Ended
Mar. 31, 2020
Segment Reporting [Abstract]  
Summary of Financial Information for Each Reportable Segment

The following table presents various financial information for each reportable segment for the three and six months ended March 31, 2020 and 2019.

 

Three months ended

 

 

Six months ended

 

 

March 31

 

 

March 31

 

(In millions - unaudited)

2020

 

 

2019

 

 

2020

 

 

2019

 

SALES

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Life Sciences

$

184

 

 

$

196

 

 

$

340

 

 

$

366

 

Personal Care & Household

 

159

 

 

 

183

 

 

 

296

 

 

 

337

 

Consumer Specialties

 

343

 

 

 

379

 

 

 

636

 

 

 

703

 

Specialty Additives

 

155

 

 

 

169

 

 

 

294

 

 

 

316

 

Performance Adhesives

 

85

 

 

 

89

 

 

 

159

 

 

 

171

 

Industrial Specialties

 

240

 

 

 

258

 

 

 

453

 

 

 

487

 

Intermediates and Solvents

 

37

 

 

 

44

 

 

 

64

 

 

 

77

 

Intersegment sales (a)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Intermediates and Solvents

 

(10

)

 

 

(14

)

 

 

(10

)

 

 

(24

)

 

$

610

 

 

$

667

 

 

$

1,143

 

 

$

1,243

 

OPERATING INCOME (LOSS)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Life Sciences

$

36

 

 

$

33

 

 

$

58

 

 

$

56

 

Personal Care & Household

 

(336

)

 

 

25

 

 

 

(326

)

 

 

42

 

Consumer Specialties

 

(300

)

 

 

58

 

 

 

(268

)

 

 

98

 

Specialty Additives

 

(161

)

 

 

(2

)

 

 

(152

)

 

 

(24

)

Performance Adhesives

 

16

 

 

 

17

 

 

 

27

 

 

 

26

 

Industrial Specialties

 

(145

)

 

 

15

 

 

 

(125

)

 

 

2

 

Intermediates and Solvents

 

(2

)

 

 

9

 

 

 

(14

)

 

 

11

 

Unallocated and other

 

(21

)

 

 

(38

)

 

 

(44

)

 

 

(74

)

 

$

(468

)

 

$

44

 

 

$

(451

)

 

$

37

 

DEPRECIATION EXPENSE

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Life Sciences

$

8

 

 

$

8

 

 

$

16

 

 

$

16

 

Personal Care & Household

 

10

 

 

 

10

 

 

 

20

 

 

 

21

 

Consumer Specialties

 

18

 

 

 

18

 

 

 

36

 

 

 

37

 

Specialty Additives

 

16

 

 

 

36

 

 

 

32

 

 

 

69

 

Performance Adhesives

 

3

 

 

 

3

 

 

 

6

 

 

 

6

 

Industrial Specialties

 

19

 

 

 

39

 

 

 

38

 

 

 

75

 

Intermediates and Solvents

 

3

 

 

 

2

 

 

 

6

 

 

 

5

 

Unallocated and other

 

 

 

 

2

 

 

 

 

 

 

3

 

 

$

40

 

 

$

61

 

 

$

80

 

 

$

120

 

 

AMORTIZATION EXPENSE

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Life Sciences

$

7

 

 

$

7

 

 

$

14

 

 

$

14

 

Personal Care & Household

 

9

 

 

 

9

 

 

 

18

 

 

 

18

 

Consumer Specialties

 

16

 

 

 

16

 

 

 

32

 

 

 

32

 

Specialty Additives

 

4

 

 

 

3

 

 

 

8

 

 

 

9

 

Performance Adhesives

 

1

 

 

 

1

 

 

 

1

 

 

 

1

 

Industrial Specialties

 

5

 

 

 

4

 

 

 

9

 

 

 

10

 

Intermediates and Solvents

 

 

 

 

1

 

 

 

1

 

 

 

1

 

 

$

21

 

 

$

21

 

 

$

42

 

 

$

43

 

EBITDA (b) (c)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Life Sciences

$

51

 

 

$

48

 

 

$

88

 

 

$

86

 

Personal Care & Household

 

(317

)

 

 

44

 

 

 

(288

)

 

 

81

 

Consumer Specialties

 

(266

)

 

 

92

 

 

 

(200

)

 

 

167

 

Specialty Additives

 

(141

)

 

 

37

 

 

 

(112

)

 

 

54

 

Performance Adhesives

 

20

 

 

 

21

 

 

 

34

 

 

 

33

 

Industrial Specialties

 

(121

)

 

 

58

 

 

 

(78

)

 

 

87

 

Intermediates and Solvents

 

1

 

 

 

12

 

 

 

(7

)

 

 

17

 

Unallocated and other

 

(21

)

 

 

(36

)

 

 

(44

)

 

 

(71

)

 

$

(407

)

 

$

126

 

 

$

(329

)

 

$

200

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

March 31, 2020

 

 

September 30, 2019

 

TOTAL ASSETS

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Life Sciences

 

 

 

 

 

 

 

 

$

1,973

 

 

$

1,946

 

Personal Care & Household

 

 

 

 

 

 

 

 

 

1,019

 

 

 

1,366

 

Consumer Specialties

 

 

 

 

 

 

 

 

 

2,992

 

 

 

3,312

 

Specialty Additives

 

 

 

 

 

 

 

 

 

1,627

 

 

 

1,775

 

Performance Adhesives

 

 

 

 

 

 

 

 

 

613

 

 

 

618

 

Industrial Specialties

 

 

 

 

 

 

 

 

 

2,240

 

 

 

2,393

 

Intermediates and Solvents

 

 

 

 

 

 

 

 

 

176

 

 

 

185

 

Unallocated and other

 

 

 

 

 

 

 

 

 

1,560

 

 

 

1,361

 

 

 

 

 

 

 

 

 

 

$

6,968

 

 

$

7,251

 

 

 

(a)

Intersegment sales from Intermediates and Solvents are accounted for at prices that approximate fair value. All other intersegment sales are accounted for at cost.

 

(b)

Excludes income (loss) from discontinued operations, other net periodic benefit income (expense) and net income (loss) on divestitures. See the Statement of Consolidated Comprehensive Income (Loss) for applicable amounts excluded.

 

(c)

Includes $20 million of accelerated depreciation for the three months ended March 31, 2019 and $39 million for the six months ended March 31, 2019.